Abstract
A bacitracin (0.04 units)-SXT (trimethoprim, 1.25 mg, plus sulfamethoxazole, 23.75 mg) susceptibility test was 94% accurate in presumptively identifying streptococci [from humans] as group A, B or not group A and B.